Valuation Alkem Laboratories Limited Bombay S.E.

Stocks

Market Closed - Bombay S.E. Other stock markets 23:57:35 2026-07-21 EDT			5-day change	1st Jan Change
5,584.45 ^INR	-1.72%		+1.50%	+3.22%

06-02	Alkem Laboratories Limited Launches Semaglutide in Single-Shot Pre-Filled Syringes At Price Starting Inr 350	CI
06-02	Alkem Laboratories Shows Strong Moves But Weak Follow-Through

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	331,171	432,909	406,055	590,890	583,680	679,223	-	-
Change	-	30.72%	-6.2%	45.52%	-1.22%	16.37%	-	-
Enterprise Value (EV) ¹	328,603	433,805	393,853	587,236	578,678	632,481	657,491	644,114
Change	-	32.02%	-9.21%	49.1%	-1.46%	9.3%	0.98%	-2.03%
P/E	20.9x	26.3x	41.3x	32.9x	27x	27.5x	29.1x	25.3x
PBR	4.49x	5.01x	4.49x	5.73x	4.87x	4.58x	4.43x	3.9x
PEG	-	6.89x	-1x	0.4x	1.3x	4.37x	-3.83x	1.7x
Capitalization / Revenue	3.74x	4.07x	3.5x	4.66x	4.5x	4.31x	4.11x	3.73x
EV / Revenue	3.71x	4.08x	3.4x	4.64x	4.46x	4.3x	3.98x	3.54x
EV / EBITDA	16.9x	21.1x	24.5x	26.2x	23x	21x	19.3x	16.6x
EV / EBIT	19.7x	24.8x	30.3x	30.2x	26.9x	24.1x	22.2x	18.9x
EV / FCF	30.4x	55.4x	27.1x	33.3x	45.3x	42.8x	36.3x	31x
FCF Yield	3.29%	1.81%	3.69%	3%	2.21%	2.33%	2.76%	3.23%
Dividend per Share ²	28	34	25	40	45	53	51.35	56.59
Rate of return	1.01%	0.94%	0.74%	0.81%	0.92%	1%	0.9%	1%
EPS ²	132.6	137.6	82.31	150.2	181.1	192.5	195.3	224.3
Distribution rate	21.1%	24.7%	30.4%	26.6%	24.8%	27.5%	26.3%	25.2%
Net sales ¹	88,650	106,342	115,993	126,676	129,645	147,123	165,371	182,166
EBITDA ¹	19,424	20,529	16,094	22,455	25,122	30,052	34,011	38,779
EBIT ¹	16,678	17,490	12,990	19,462	21,550	26,232	29,653	34,085
Net income ¹	15,850	16,456	9,842	17,958	21,655	23,018	23,589	27,377
Net Debt ¹	-2,568	896.1	-12,202	-3,654	-5,003	-1,094	-21,733	-35,109
Reference price ²	2,769.80	3,620.70	3,396.10	4,942.00	4,881.70	5,681.50	5,681.50	5,681.50
Nbr of stocks (in thousands)	119,565	119,565	119,565	119,565	119,565	119,550	-	-
Announcement Date	5/25/21	5/13/22	5/19/23	5/29/24	5/29/25	5/28/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.09x	12.2x	25.51x	0.59%	1,023B
JOHNSON & JOHNSON	26.74x	6.1x	16.7x	2.16%	599B
ABBVIE INC.	33.01x	7.5x	15.37x	2.71%	448B
ROCHE HOLDING AG	17.72x	4.39x	10.82x	3.02%	326B
NOVARTIS AG	21.23x	5.45x	13.2x	2.93%	278B
ASTRAZENECA PLC	20.75x	4.38x	12.12x	2.01%	258B
NOVO NORDISK A/S	14.46x	5.38x	11.08x	3.46%	222B
AMGEN INC.	23.89x	6.31x	11.13x	2.77%	197B
GILEAD SCIENCES, INC.	-47.99x	5.74x	31.73x	2.44%	165B
Average	15.99x	6.38x	16.41x	2.45%	390.56B
Weighted average by Cap.	23.51x	7.66x	17.98x	2.03%